中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2014年
6期
446-448
,共3页
张锋%朱莲%陈军%高孟%唐彩华%周康凤%高丽美%罗永能
張鋒%硃蓮%陳軍%高孟%唐綵華%週康鳳%高麗美%囉永能
장봉%주련%진군%고맹%당채화%주강봉%고려미%라영능
肠道病毒B型,人%细胞,生理学%病毒培养
腸道病毒B型,人%細胞,生理學%病毒培養
장도병독B형,인%세포,생이학%병독배양
Entervirus B,human%Cells physiology%Virus cultivation
目的 探索柯萨奇病毒A16型(CVA16) YY157株在非洲绿猴肾(Vero)细胞中培养与增殖的合适条件.方法 把CVA16 YY157株接种于Vero细胞适应性传代,挑斑纯化后,在不同条件下培养并比较其对病毒滴度的影响.结果 CVA16 YY157株在Vero细胞中培养能导致细胞病变(CPE),可形成蚀斑.将此CVA16病毒以0.01 ~0.1MOI接种于Vero细胞,并在低于2%牛血清浓度的培养基,35℃培养60 h,CPE可达90%以上;此条件下收获培养液上清,可得到较高滴度的病毒.结论 初步建立了CVA16 YY157株在Vero细胞中培养与增殖的方法,为其下一步的大规模培养及疫苗制备奠定了基础.
目的 探索柯薩奇病毒A16型(CVA16) YY157株在非洲綠猴腎(Vero)細胞中培養與增殖的閤適條件.方法 把CVA16 YY157株接種于Vero細胞適應性傳代,挑斑純化後,在不同條件下培養併比較其對病毒滴度的影響.結果 CVA16 YY157株在Vero細胞中培養能導緻細胞病變(CPE),可形成蝕斑.將此CVA16病毒以0.01 ~0.1MOI接種于Vero細胞,併在低于2%牛血清濃度的培養基,35℃培養60 h,CPE可達90%以上;此條件下收穫培養液上清,可得到較高滴度的病毒.結論 初步建立瞭CVA16 YY157株在Vero細胞中培養與增殖的方法,為其下一步的大規模培養及疫苗製備奠定瞭基礎.
목적 탐색가살기병독A16형(CVA16) YY157주재비주록후신(Vero)세포중배양여증식적합괄조건.방법 파CVA16 YY157주접충우Vero세포괄응성전대,도반순화후,재불동조건하배양병비교기대병독적도적영향.결과 CVA16 YY157주재Vero세포중배양능도치세포병변(CPE),가형성식반.장차CVA16병독이0.01 ~0.1MOI접충우Vero세포,병재저우2%우혈청농도적배양기,35℃배양60 h,CPE가체90%이상;차조건하수획배양액상청,가득도교고적도적병독.결론 초보건립료CVA16 YY157주재Vero세포중배양여증식적방법,위기하일보적대규모배양급역묘제비전정료기출.
Objective To explore optimal culture conditions for proliferation of Coxsackievirus 16 (CVA16) strain YY157 in vero cells.Methods CVA16 strain YY157 strain was inoculated into vero cells and adapted by passage culturing.The proliferation condition of CAV16 was investigated after plaquepurified.Results CVA16 strain YY157 could induce cytopathic effect (CPE) and visible plaques in vero cell culture.After inoculating the virus at a MOI of 0.01-0.1 into vero cells and cultured for 60 h at 35 ℃ in medium containing less than 2% bovine serum,more than 90% cells showed CPE.The culture supernatant was harvested and a relatively high titer of CVA16 could be obtained.Conclusion A procedure for incubation and proliferation of CVA16 strain YY157 in vero cells was established,which provides a basis for its large-scale culture and vaccine development.